Analysts think MDXG stock price could increase by 45%
Dec 25, 2024, 12:25 PM
-1.10%
What does MDXG do
MiMedx Group, headquartered in Marietta, Georgia, specializes in therapeutic biologics, focusing on placental tissue allografts for wound care and surgical applications. The company, founded in 2007, employs 895 staff and offers various patented products.
7 analysts think MDXG stock price will increase by 45.24%. The current median analyst target is $13.26 compared to a current stock price of $9.13. The lowest analysts target is $12.12 and the highest analyst target is $14.70.
📡️ Health Care
Price Target
More Signals
Feature in Progress
This section is under development. Check back soon for updates!
